24

October

featured image

US life sciences firm BioClavis sets up base in Glasgow

BioClavis has announced the planned creation of 43 new jobs with a £10.5 million investment supported by Scottish Enterprise.

Bioclavis is a new spin-out from Californian molecular profiling company Biospyder, to be based at the Clinical Innovation Zone at Glasgow’s Queen Elizabeth University Hospital, creating 43 new jobs.

BioSpyder’s investment has been supported by a £4.5m Seek & Solve research and development grant from Scottish Enterprise. It forms part of a total investment of £10.5m, which will see BioClavis adapt BioSpyder’s TempO-Seq platform technology into a novel diagnostic tool for precision medicine in a number of high value clinical indications, in close collaboration with the health service and university researchers.

Joel McComb, CEO of BioSpyder and BioClavis said: “We’re very excited to build on the success we’ve had in other molecular profiling applications and bring this novel method to bear on discovery and deployment of next generation genomic diagnostics.

“We determined Glasgow, Scotland to be the ideal location for this initiative based in large part on the support and close working relationships with Scottish Enterprise, NHS and the University.”

Read the original news release from Scottish Enterprise


Fill out the form below and one of our experts will contact you. Office hours are Monday - Friday, 9:00 - 17:00.







Briefly describe how we can help. Please be as specific as you can with your enquiry so that we can efficiently deal with your query.


captcha


Latest News

Award Winning City

Glasgow has received a number of accolades which demonstrate its world class standing as a dynamic, 21st-century city. Read More

Glasgow named cultural and creative ‘centre’ of UK

Glasgow has been listed as the top cultural and creative centre in the UK in a report from the...Read More

Glasgow wins European Capital of Sport title

Glasgow has succeeded in its bid to be named the European Capital of Sport in 2023. The announcement, made...Read More

News by Sector

News Archive

Email Alerts

Sign-up to our email updates for the latest investment opportunities and information in Glasgow. Fill out the form below with your email.